Litera has announced Immunocore, a leading biotechnology company headquartered in Oxford, UK, has recently chosen to implement DocXtools for Life Sciences. The company will roll out the solution to its medical writers, complementing their drafting workflow and enabling them to repair their documents faster and more efficiently.
Matt Miller, Litera Director of Life Sciences Products, said, “Immunocore, a top biotechnology company committed to delivering first-in-class biological therapies that have the potential to transform the lives of people with serious diseases, has chosen to leverage our products to reduce time spent repairing documents. We’re excited to work with their team as they continue to invest in technology that encourages the development of the company’s pipeline for proprietary and partnered programs.”
Litera is the leading provider of software for managing transactions and drafting, proofreading, comparing, repairing, cleaning, and securing documents in the legal and corporate industries worldwide. Our core products empower users to generate, review, and distribute high-quality content quickly and securely, from any device. Today, Litera supports thousands of document-intensive organizations across the globe, helping them satisfy the complex demands of clients and regulators.
Posted in DocXtools